- Home
- MRBK vs RPTX Comparison
MRBK vs RPTX Comparison
Compare MRBK & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRBK
- RPTX
- Stock Information
- Founded
- MRBK 2004
- RPTX 2016
- Country
- MRBK United States
- RPTX Canada
- Employees
- MRBK N/A
- RPTX N/A
- Industry
- MRBK Major Banks
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- MRBK Finance
- RPTX Health Care
- Exchange
- MRBK Nasdaq
- RPTX Nasdaq
- Market Cap
- MRBK 145.8M
- RPTX 63.9M
- IPO Year
- MRBK 2017
- RPTX 2020
- Fundamental
- Price
- MRBK $13.67
- RPTX $1.43
- Analyst Decision
- MRBK Buy
- RPTX Strong Buy
- Analyst Count
- MRBK 2
- RPTX 3
- Target Price
- MRBK $17.00
- RPTX $4.50
- AVG Volume (30 Days)
- MRBK 102.7K
- RPTX 91.8K
- Earning Date
- MRBK 07-25-2025
- RPTX 08-05-2025
- Dividend Yield
- MRBK 3.88%
- RPTX N/A
- EPS Growth
- MRBK 33.85
- RPTX N/A
- EPS
- MRBK 1.42
- RPTX N/A
- Revenue
- MRBK $101,096,000.00
- RPTX $1,073,000.00
- Revenue This Year
- MRBK $20.44
- RPTX N/A
- Revenue Next Year
- MRBK $10.56
- RPTX N/A
- P/E Ratio
- MRBK $9.10
- RPTX N/A
- Revenue Growth
- MRBK 8.82
- RPTX N/A
- 52 Week Low
- MRBK $10.04
- RPTX $0.89
- 52 Week High
- MRBK $17.33
- RPTX $4.29
- Technical
- Relative Strength Index (RSI)
- MRBK 52.20
- RPTX 54.16
- Support Level
- MRBK $11.16
- RPTX $1.40
- Resistance Level
- MRBK $13.11
- RPTX $1.45
- Average True Range (ATR)
- MRBK 0.50
- RPTX 0.05
- MACD
- MRBK 0.11
- RPTX -0.01
- Stochastic Oscillator
- MRBK 77.00
- RPTX 44.00
About MRBK Meridian Corporation
Meridian Corp is a bank holding company. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal, business lending, and deposit services. It operates in three reportable segments including Bank, Wealth, and Mortgage. The company generates maximum revenue from the Bank segment which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.